BIVI (BIVI) Stock Price & Analysis
BIVI (BIVI) rose 3.50% to USD 2.07 as of September 9, 2026 at 12:07 UTC, according to Nexqual real-time market data.
BIVI last closed at USD 2.07; the session ranged USD 2–2.2 on volume of 318,488 shares. Market capitalization is —, with a 52-week range of USD 0.82–3.79 (NCM). Source: Nexqual, September 9, 2026 at 12:07 UTC.
Key Statistics (as of September 9, 2026 at 12:07 UTC)
| Price | USD 2.07 |
|---|---|
| Change | ▲ 3.50% (up) |
| Previous Close | USD 2.07 |
| Open | USD 2.07 |
| Day Range | USD 2 – 2.2 |
| 52-Week Range | USD 0.82 – 3.79 |
| Volume | 318,488 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (BIVI)
Nexqual's technical model rates BIVI "STRONG BUY" based on 5 bullish and 0 bearish signals across 127 daily candles, as of September 9, 2026 at 12:07 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 57.95 (neutral) |
| vs SMA50 | Above (USD 1.73) |
| MACD | 0.15 (positive) |
From BIVI's Latest SEC 10-K Filing (filed 2026-08-13)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ENSC | Ensysce Biosciences, Inc. | USD 0.47 | ▲ 7.5% |
| BCDA | BioCardia, Inc. | USD 1.11 | ▲ 1.83% |
| TNON | Tenon Medical, Inc. | USD 3.36 | ▼ 10.88% |
| GRI | GRI Bio, Inc. | USD 2 | ▼ 12.66% |
| DRUG | Bright Minds Biosciences Inc. | USD 66.91 | ▼ 1.63% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 12:07 UTC. This page is informational and not investment advice.